These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 32339634)

  • 1. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study.
    Arduino I; Depalo N; Re F; Dal Magro R; Panniello A; Margiotta N; Fanizza E; Lopalco A; Laquintana V; Cutrignelli A; Lopedota AA; Franco M; Denora N
    Int J Pharm; 2020 Jun; 583():119351. PubMed ID: 32339634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.
    Liu B; Han L; Liu J; Han S; Chen Z; Jiang L
    Int J Nanomedicine; 2017; 12():955-968. PubMed ID: 28203075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo studies of ocular topically administered NLC for the treatment of uveal melanoma.
    Cimino C; Sánchez López E; Bonaccorso A; Bonilla L; Musumeci T; Badia J; Baldomà L; Pignatello R; Marrazzo A; Barbaraci C; García ML; Carbone C
    Int J Pharm; 2024 Jul; 660():124300. PubMed ID: 38851409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer.
    Huang H; Dong Y; Zhang Y; Ru D; Wu Z; Zhang J; Shen M; Duan Y; Sun Y
    Theranostics; 2019; 9(4):1047-1065. PubMed ID: 30867815
    [No Abstract]   [Full Text] [Related]  

  • 5. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
    Johnstone TC; Suntharalingam K; Lippard SJ
    Chem Rev; 2016 Mar; 116(5):3436-86. PubMed ID: 26865551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.
    Tapeinos C; Battaglini M; Ciofani G
    J Control Release; 2017 Oct; 264():306-332. PubMed ID: 28844756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation.
    De Gaetano F; Cristiano MC; Venuti V; Crupi V; Majolino D; Paladini G; Acri G; Testagrossa B; Irrera A; Paolino D; Tommasini S; Ventura CA; Stancanelli R
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33669321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance.
    Ling X; Chen X; Riddell IA; Tao W; Wang J; Hollett G; Lippard SJ; Farokhzad OC; Shi J; Wu J
    Nano Lett; 2018 Jul; 18(7):4618-4625. PubMed ID: 29902013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.
    Brioschi A; Zara GP; Calderoni S; Gasco MR; Mauro A
    Molecules; 2008 Feb; 13(2):230-54. PubMed ID: 18305415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.
    Stewart TS; Nagesetti A; Guduru R; Liang P; Stimphil E; Hadjikhani A; Salgueiro L; Horstmyer J; Cai R; Schally A; Khizroev S
    Nanomedicine (Lond); 2018 Feb; 13(4):423-438. PubMed ID: 29345190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles.
    Kumar V; Hong SY; Maciag AE; Saavedra JE; Adamson DH; Prud'homme RK; Keefer LK; Chakrapani H
    Mol Pharm; 2010 Feb; 7(1):291-8. PubMed ID: 20000791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminescent Alendronic Acid-Conjugated Micellar Nanostructures for Potential Application in the Bone-Targeted Delivery of Cholecalciferol.
    Rizzi F; Panniello A; Comparelli R; Arduino I; Fanizza E; Iacobazzi RM; Perrone MG; Striccoli M; Curri ML; Scilimati A; Denora N; Depalo N
    Molecules; 2024 May; 29(10):. PubMed ID: 38792228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme.
    Jnaidi R; Almeida AJ; Gonçalves LM
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple conjugated carbon dots as a nano-drug delivery model for glioblastoma brain tumors.
    Hettiarachchi SD; Graham RM; Mintz KJ; Zhou Y; Vanni S; Peng Z; Leblanc RM
    Nanoscale; 2019 Mar; 11(13):6192-6205. PubMed ID: 30874284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles.
    Anand A; Sugumaran A; Narayanasamy D
    IET Nanobiotechnol; 2019 Jun; 13(4):353-362. PubMed ID: 31171738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands.
    Li X; Liu Y; Tian H
    Bioinorg Chem Appl; 2018; 2018():8276139. PubMed ID: 30402082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial charge configuration regulates nanoparticle transport and binding behavior in vivo.
    Han HS; Martin JD; Lee J; Harris DK; Fukumura D; Jain RK; Bawendi M
    Angew Chem Int Ed Engl; 2013 Jan; 52(5):1414-9. PubMed ID: 23255143
    [No Abstract]   [Full Text] [Related]  

  • 18. Naringenin Nanoformulations for Neurodegenerative Diseases.
    Sahoo L; Tripathy NS; Dilnawaz F
    Curr Pharm Biotechnol; 2024; 25(16):2108-2124. PubMed ID: 38347794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the Interaction Between Solid Lipid Nanoparticles and Alveolar Macrophages Via the Label-Free Technique.
    Paul PK; Wu W; Srichana T
    J Pharm Sci; 2024 Aug; 113(8):2223-2231. PubMed ID: 38492846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA.
    Li B; Luo X; Deng B; Giancola JB; McComb DW; Schmittgen TD; Dong Y
    Sci Rep; 2016 Feb; 6():22137. PubMed ID: 26916931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.